Clinical Trials on Subjects With Primary Open-angle Glaucoma (POAG)

Total 899 results

Glaukos Corporation

Completed

Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStents

Subjects With Primary Open-angle Glaucoma (POAG)

Armenia
Glaukos Corporation

Completed

Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStents

Subjects With Primary Open-angle Glaucoma (POAG)

Armenia
Glaukos Corporation

Completed

A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal Stent

Subject With Primary Open-angle Glaucoma (POAG)

Armenia
Maisonneuve-Rosemont Hospital

Recruiting

Visual Outcomes of Vivity in Patients With Well Controlled Glaucoma

Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Canada
Transcend Medical, Inc.

Completed

Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy (DUETTE)

Primary Open Angle Glaucoma (POAG)
Implandata Ophthalmic Products GmbH

Completed

Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG)

Primary Open Angle Glaucoma (POAG)

Germany
University Hospital, Grenoble

Not yet recruiting

Role of Peripheral Vision in Scene Perception (PERISCE) (PERISCE)

Primary Open-angle Glaucoma (POAG)
Alcon Research
Transcend Medical, Inc.

Completed

A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial (COMPASS-XT)

Primary Open Angle Glaucoma (POAG)

United States
Glaukos Corporation

Completed

Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

Primary Open Angle Glaucoma (POAG)

Armenia
Glaukos Corporation

Terminated

iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications

Primary Open Angle Glaucoma (POAG)

Brazil
Glaukos Corporation

Completed

One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

Primary Open Angle Glaucoma (POAG)

Armenia
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure (PREDICOM)

Ocular Hypertension | Glaucoma, Primary Open Angle (POAG)

France
Transcend Medical, Inc.

Completed

Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery (COMPASS)

Cataract | Primary Open Angle Glaucoma (POAG)
Qlaris Bio, Inc.

Recruiting

Qlaris Phase 2 Study of QLS-111 in POAG and/or OHT Patients

Primary Open Angle Glaucoma of Both Eyes | Primary Open Angle Glaucoma (POAG) | Primary Open-Angle Glaucoma, Unspecified Eye | Ocular Hypertension (OHT)

United States
Shire

Completed

Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma

Ocular Hypertension | Primary Open-angle Glaucoma (POAG)

United States
Sensimed AG

Terminated

Intraocular Pressure (IOP) Patterns in Fast Versus Slow Visual Field (VF) Progression Patients

Primary Open-angle Glaucoma (POAG) Patient

United States
Centre Hospitalier Universitaire, Amiens
Central Hospital Saint Quentin

Recruiting

Efficacy and Safety of iStent Inject and Inject W in the Management of Primary Open-angle Glaucoma (EII)

POAG | MIGS

France
Daniel Moore
Pfizer

Terminated

Safety Study of Latanoprost Slow Release Insert (Latanoprost SR)

Primary Open Angle Glaucoma (POAG) | Ocular Hypertension (OHT)

United States
Dr. David Yan
Allergan

Unknown

A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma

Primary Open Angle Glaucoma | Ocular Hypertension | POAG

Canada
Inotek Pharmaceuticals Corporation

Completed

Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG

Ocular Hypertension (OHT) | Primary Open-Angle Glaucoma (POAG)

United States
Inotek Pharmaceuticals Corporation

Completed

A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma

Ocular Hypertension (OHT) | Primary Open-Angle Glaucoma (POAG)

United States
OcuTherix, Inc.

Terminated

Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension

Primary Open-angle Glaucoma (POAG) | Ocular Hypertension (OHT)

Philippines
Inotek Pharmaceuticals Corporation

Completed

Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma (MATrX-1)

Ocular Hypertension (OHT) | Primary Open-Angle Glaucoma (POAG)

United States
New World Medical, Inc.

Not yet recruiting

Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma

POAG

Costa Rica, Honduras, Mexico
University Hospital Tuebingen
Alcon Research

Unknown

Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients (TRASCO)

Primary Open Angle Glaucoma (POAG)

Germany
Transcend Medical, Inc.

Completed

Safety and Performance Study of the CyPass System Applier Model 241 (RePASS)

Open Angle Glaucoma (OAG)

Germany
AbbVie

Recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China

Open-angle Glaucoma | OAG

China
Transcend Medical, Inc.

Completed

CyPass Clinical Experience Study (CyCLE)

Open Angle Glaucoma (OAG)

Spain, Austria, Bulgaria, Germany, Italy, Poland
Alcon Research

Completed

Travoprost Five Day Posology Study

Ocular Hypertension | Open-angle Glaucoma (OAG)

United States
Sensimed AG

Completed

Efficacy of 24-hour Intraocular Pressure Fluctuation Recording With the SENSIMED Triggerfish Contact Lens Sensor

Primary Open Angle Glaucoma | Healthy Subjects

United States
Alcon Research

Completed

AL-54478 Proof of Concept Study

Open-angle Glaucoma (OAG) | Ocular Hypertension (OHT)
Belkin Laser Ltd.

Completed

Evaluation of the Compatibility of Different Eye Lid Retractors to the Direct Selective Laser Trabeculoplasty (DSLT) Procedure

OAG - Open-Angle Glaucoma

Georgia
Qlaris Bio, Inc.

Recruiting

Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients

Glaucoma | Open-angle Glaucoma (OAG) | Ocular Hypertension (OHT)

United States
University of California, San Diego
Bausch & Lomb Incorporated

Completed

Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity

OAG - Open-Angle Glaucoma | OHT - Ocular Hypertension

United States
University of California, San Diego
Aerie Pharmaceuticals

Withdrawn

Effects of Netarsudil and Timolol on Retinal Blood Vessel Density and Visual Acuity

OAG - Open-Angle Glaucoma | OHT - Ocular Hypertension
Rabin Medical Center

Unknown

Protective Effect of Phenytoin on Glaucoma

Primary Open Angle Glaucoma | Normal Tension Glaucoma | Secondary Open Angle Glaucoma | Narrow-Angle Glaucomas

Israel
Ono Pharma USA Inc

Completed

Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma

Ocular Hypertension (OHT) | Mild Open Angle-glaucoma (OAG)

United States
Wills Eye

Completed

Comparison of Gonioscopy With Cirrus and Visante (ASOCT)

Open Angle Glaucoma | Angle Closure Glaucoma | Narrow Angles

United States
Omar Said

Completed

Comparison of Optical Coherence Tomography Angiography Microvascular Changes in Primary Open Angle and Primary Angle Closure Glaucoma

Glaucoma,Primary Open-Angle ,Primary Angle Closure

Egypt
University Hospital, Bordeaux

Completed

Corneal Biomechanics and Continuous IOP Monitoring Using Soft Contact Lenses in Glaucomatous Patients (BIOLENS)

Open Angle Glaucoma With a Progressive Visual Field

France
Glaucot Teknoloji Anonim Sirketi

Recruiting

GlaucoT Glaucoma Treatment Glasses in the Treatment of Primary Open-Angle Glaucoma (GlaucoT)

Primary Open-Angle Glaucoma

Turkey
China Medical University Hospital

Completed

Effect of Acupuncture on Visual Acuity and Visual Field in Patients With Primary Open-angle Glaucoma

Primary Open-angle Glaucoma

Taiwan
InnFocus Inc.

Completed

PRESERFLO® MicroShunt Extension Study

Primary Open-angle Glaucoma

Spain, United States, United Kingdom, France, Italy
Glaukos Corporation

Terminated

Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty

Primary Open-Angle Glaucoma

United States
Rehab mahmoud abdelhamid mohamed
Cairo University

Completed

Modified Trabeculectomy With an ESST Versus Conventional SST for Management of Primary Open Angle Glaucoma (POAG)

Primary Open-angle Glaucoma

Egypt
Cairo University
University of Luebeck

Unknown

Decorin in Sub Scleral Trabeculectomy

Primary Open-angle Glaucoma

Egypt
Xiaodong Zhou

Completed

Study of Vitamin A and Carbomer in Comforting the Ocular Surface Irritations of Glaucoma Patients

Primary Open-angle Glaucoma
Peking University

Recruiting

Glaucoma Screening Using Dynamic Analysis of Computerized Pupillary Light Reflex Assessment Device

Primary Open Angle Glaucoma | Ocular Hypertension | Primary Open Angle Glaucoma of Both Eyes | Primary Open-Angle Glaucoma, Unspecified Eye | Suspect Glaucoma

China
University of Alabama at Birmingham
National Institute on Aging (NIA)

Active, not recruiting

Impact of Glaucoma and Visual Field Loss on Life Space

Primary Open-angle Glaucoma

United States
Implandata Ophthalmic Products GmbH

Completed

Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG)

Primary Open-angle Glaucoma

Germany

Clinical Trials on Subjects With Primary Open-angle Glaucoma (POAG)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations